Annual Accounts Payable
$1.61 M
+$843.00 K+109.20%
December 31, 2024
Summary
- As of March 14, 2025, PTGX annual accounts payable is $1.61 million, with the most recent change of +$843.00 thousand (+109.20%) on December 31, 2024.
- During the last 3 years, PTGX annual accounts payable has risen by +$15.00 thousand (+0.94%).
- PTGX annual accounts payable is now -71.72% below its all-time high of $5.71 million, reached on December 31, 2018.
Performance
PTGX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.61 M
-$1.43 M-47.03%
December 31, 2024
Summary
- As of March 14, 2025, PTGX quarterly accounts payable is $1.61 million, with the most recent change of -$1.43 million (-47.03%) on December 31, 2024.
- Over the past year, PTGX quarterly accounts payable has dropped by -$1.43 million (-47.03%).
- PTGX quarterly accounts payable is now -79.57% below its all-time high of $7.91 million, reached on June 30, 2021.
Performance
PTGX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PTGX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +109.2% | -47.0% |
| 3 y3 years | +0.9% | -47.0% |
| 5 y5 years | -42.1% | -47.0% |
PTGX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.6% | +109.2% | -77.4% | +109.2% |
| 5 y | 5-year | -55.6% | +109.2% | -79.6% | +128.8% |
| alltime | all time | -71.7% | +362.8% | -79.6% | +128.8% |
Protagonist Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.61 M(+109.2%) | $1.61 M(-47.0%) |
| Sep 2024 | - | $3.05 M(-16.0%) |
| Jun 2024 | - | $3.63 M(+3.5%) |
| Mar 2024 | - | $3.51 M(+354.3%) |
| Dec 2023 | $772.00 K(-78.8%) | $772.00 K(-38.3%) |
| Sep 2023 | - | $1.25 M(-72.6%) |
| Jun 2023 | - | $4.57 M(+13.7%) |
| Mar 2023 | - | $4.02 M(+10.5%) |
| Dec 2022 | $3.64 M(+127.5%) | $3.64 M(-22.8%) |
| Sep 2022 | - | $4.71 M(+233.9%) |
| Jun 2022 | - | $1.41 M(-80.3%) |
| Mar 2022 | - | $7.16 M(+347.4%) |
| Dec 2021 | $1.60 M(-48.0%) | $1.60 M(+126.6%) |
| Sep 2021 | - | $706.00 K(-91.1%) |
| Jun 2021 | - | $7.91 M(+189.3%) |
| Mar 2021 | - | $2.73 M(-11.2%) |
| Dec 2020 | $3.08 M | $3.08 M(+9.9%) |
| Sep 2020 | - | $2.80 M(-2.0%) |
| Jun 2020 | - | $2.85 M(-22.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.70 M(+32.8%) |
| Dec 2019 | $2.79 M(-51.1%) | $2.79 M(+76.2%) |
| Sep 2019 | - | $1.58 M(-43.2%) |
| Jun 2019 | - | $2.79 M(-56.8%) |
| Mar 2019 | - | $6.45 M(+13.0%) |
| Dec 2018 | $5.71 M(+354.3%) | $5.71 M(+17.2%) |
| Sep 2018 | - | $4.87 M(+113.8%) |
| Jun 2018 | - | $2.28 M(+74.3%) |
| Mar 2018 | - | $1.31 M(+4.0%) |
| Dec 2017 | $1.26 M(+8.1%) | $1.26 M(-44.6%) |
| Sep 2017 | - | $2.27 M(-14.1%) |
| Jun 2017 | - | $2.64 M(+133.1%) |
| Mar 2017 | - | $1.13 M(-2.7%) |
| Dec 2016 | $1.16 M(-6.7%) | $1.16 M(-50.2%) |
| Sep 2016 | - | $2.33 M(+62.0%) |
| Jun 2016 | - | $1.44 M(-23.8%) |
| Mar 2016 | - | $1.89 M(+51.6%) |
| Dec 2015 | $1.25 M(+257.3%) | $1.25 M |
| Dec 2014 | $349.00 K | - |
FAQ
- What is Protagonist Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual accounts payable year-on-year change?
- What is Protagonist Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
What is Protagonist Therapeutics annual accounts payable?
The current annual accounts payable of PTGX is $1.61 M
What is the all time high annual accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual accounts payable is $5.71 M
What is Protagonist Therapeutics annual accounts payable year-on-year change?
Over the past year, PTGX annual accounts payable has changed by +$843.00 K (+109.20%)
What is Protagonist Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PTGX is $1.61 M
What is the all time high quarterly accounts payable for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly accounts payable is $7.91 M
What is Protagonist Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PTGX quarterly accounts payable has changed by -$1.43 M (-47.03%)